Chun H

References (6)

Title : Multifunctional antibacterial micelle with targeting ability and lipase-responsibility for therapy of methicillin-resistant Staphylococcus aureus infection - Chun_2025_Int.Immunopharmacol_165_115499
Author(s) : Chun H , Wang S , Shi Q , Erbu A , Ye B , Xie H
Ref : Int Immunopharmacol , 165 :115499 , 2025
Abstract :
PubMedSearch : Chun_2025_Int.Immunopharmacol_165_115499
PubMedID: 40945029

Title : Multifunctional antibacterial micelle with targeting ability and lipase-responsibility for therapy of methicillin-resistant Staphylococcus aureus infection - Chun_2025_Int.Immunopharmacol_165_115499
Author(s) : Chun H , Wang S , Shi Q , Erbu A , Ye B , Xie H
Ref : Int Immunopharmacol , 165 :115499 , 2025
Abstract :
PubMedSearch : Chun_2025_Int.Immunopharmacol_165_115499
PubMedID: 40945029

Title : Multifunctional antibacterial micelle with targeting ability and lipase-responsibility for therapy of methicillin-resistant Staphylococcus aureus infection - Chun_2025_Int.Immunopharmacol_165_115499
Author(s) : Chun H , Wang S , Shi Q , Erbu A , Ye B , Xie H
Ref : Int Immunopharmacol , 165 :115499 , 2025
Abstract :
PubMedSearch : Chun_2025_Int.Immunopharmacol_165_115499
PubMedID: 40945029

Title : Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease - Park_2019_Sci.Adv_5_eaav0316
Author(s) : Park JH , Ju YH , Choi JW , Song HJ , Jang BK , Woo J , Chun H , Kim HJ , Shin SJ , Yarishkin O , Jo S , Park M , Yeon SK , Kim S , Kim J , Nam MH , Londhe AM , Cho SJ , Cho S , Lee C , Hwang SY , Kim SW , Oh SJ , Cho J , Pae AN , Lee CJ , Park KD
Ref : Sci Adv , 5 :eaav0316 , 2019
Abstract :
PubMedSearch : Park_2019_Sci.Adv_5_eaav0316
PubMedID: 30906861

Title : Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease - Park_2019_Sci.Adv_5_eaav0316
Author(s) : Park JH , Ju YH , Choi JW , Song HJ , Jang BK , Woo J , Chun H , Kim HJ , Shin SJ , Yarishkin O , Jo S , Park M , Yeon SK , Kim S , Kim J , Nam MH , Londhe AM , Cho SJ , Cho S , Lee C , Hwang SY , Kim SW , Oh SJ , Cho J , Pae AN , Lee CJ , Park KD
Ref : Sci Adv , 5 :eaav0316 , 2019
Abstract :
PubMedSearch : Park_2019_Sci.Adv_5_eaav0316
PubMedID: 30906861

Title : Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease - Park_2019_Sci.Adv_5_eaav0316
Author(s) : Park JH , Ju YH , Choi JW , Song HJ , Jang BK , Woo J , Chun H , Kim HJ , Shin SJ , Yarishkin O , Jo S , Park M , Yeon SK , Kim S , Kim J , Nam MH , Londhe AM , Cho SJ , Cho S , Lee C , Hwang SY , Kim SW , Oh SJ , Cho J , Pae AN , Lee CJ , Park KD
Ref : Sci Adv , 5 :eaav0316 , 2019
Abstract :
PubMedSearch : Park_2019_Sci.Adv_5_eaav0316
PubMedID: 30906861